CAMP4 Therapeutics Corporation
Price Action
Technical Summary
EMERGING TRENDCAMP4 Therapeutics Corporation shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings growth of 20% provides fundamental context to the price action. Investors should exercise caution due to high volatility (123% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.15 | +8.22% | ABOVE |
| 50 SMA | $4.94 | -9.12% | BELOW |
| 100 SMA | $4.45 | +0.84% | ABOVE |
| 150 SMA | $3.66 | +22.84% | ABOVE |
| 200 SMA | $3.17 | +41.69% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CAMP in an uptrend right now?
CAMP has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is CAMP overbought or oversold?
CAMP's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.
Is CAMP outperforming the market?
CAMP has a Relative Strength (RS) Rating of 93 out of 99. Yes, CAMP is a market leader, outperforming 93% of all stocks over the past 12 months.
Where is CAMP in its 52-week range?
CAMP is trading at $4.49, which is 61% of its 52-week high ($7.30) and 53% above its 52-week low ($1.31).
How volatile is CAMP?
CAMP has a Beta of 0.52 and 52-week volatility of 123%. It's less volatile than the S&P 500 - generally more stable.